XML 47 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 62.76    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 11,130   $ 11,130    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.33   $ 59.33   $ 57.75
Share-based Compensation Arrangement By Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding [Roll Forward]          
Beginning of Year (in shares) 1,523,126   1,523,126    
Grants in Period (in shares) 8,402 0 499,631 443,731  
Exercises in Period (in shares)     158,279    
Forfeitures in Period (in shares)     135,511    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     $ 39.63    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     68.78    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 58.09   $ 58.09    
Weighted Average Remaining Contractual Term, Outstanding (in years)     6 years 7 months    
Weighted Average Remaining Contractual Term, Exercisable (in years)     5 years 2 months    
Aggregate Intrinsic Value, Outstanding $ 13,624   $ 13,624    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,444,448   2,444,448   2,238,607